ArticleProceedings of the National Academy of Sciences of the United States of America1997
A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets.
Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 128 citations in OpenAlex.
- The Use of Yeast in Biosensing.Microorganisms · 2022Review
- Article
- Review
- Network-based study reveals potential infection pathways of hepatitis-C leading to various diseases.PloS one · 2014Article
- On the binding affinity of macromolecular interactions: daring to ask why proteins interact.Journal of the Royal Society, Interface · 2013Review
- Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.Microbiology and molecular biology reviews : MMBR · 2012Review
- A novel biclustering approach to association rule mining for predicting HIV-1-human protein interactions.PloS one · 2012Article
- Fluorescence protection assay: a novel homogeneous assay platform toward development of aptamer sensors for protein detection.Nucleic acids research · 2011Article
- An intein with genetically selectable markers provides a new approach to internally label proteins with GFP.BMC biotechnology · 2011Article
- Yeast two-hybrid, a powerful tool for systems biology.International journal of molecular sciences · 2009Review
- High-throughput selection for cellulase catalysts using chemical complementation.Journal of the American Chemical Society · 2008Article
- Detecting bacteria and determining their susceptibility to antibiotics by stochastic confinement in nanoliter droplets using plug-based microfluidics.Lab on a chip · 2008Article
- Resolving the network of cell signaling pathways using the evolving yeast two-hybrid system.BioTechniques · 2008Review
- A yeast two-hybrid smart-pool-array system for protein-interaction mapping.Nature methods · 2007Article
- A systematic method for identifying small-molecule modulators of protein-protein interactions.Proceedings of the National Academy of Sciences of the United States of America · 2004Article
- The yeast two-hybrid system and its pharmaceutical significance.Pharmaceutical research · 2000Review
- Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action.Clinical microbiology reviews · 1999Review
- Probing the molecular environment of membrane proteins in vivo.Molecular biology of the cell · 1999Article
- Cytoplasmic RNA modulators of an inside-out signal-transduction cascade.Proceedings of the National Academy of Sciences of the United States of America · 1999Article
- Network and pathway enrichment analysis of Attention Deficit/Hyperactivity Disorder candidate genes.Indian journal of psychiatryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellular processes are mediated by complex networks of molecular interactions. Dissection of their role most commonly is achieved by using genetic mutations that alter, for example, protein-protein interactions. Small molecules that accomplish the same result would provide a powerful complement to the genetic approach, but it generally is believed that such molecules are rare. There are several natural products, however, that illustrate the feasibility of this approach. Split-pool synthesis now provides a simple mechanical means to prepare vast numbers of complex, even natural product-like, molecules individually attached to cell-sized polymer beads. Here, we describe a genetic system compatible with split-pool synthesis that allows the detection of cell-permeable, small molecule inhibitors of protein-protein interactions in 100- to 200-nl cell culture droplets, prepared by a recently described technique that arrays large numbers of such droplets. These "nanodroplets" contain defined media, cells, and one or more beads containing approximately 100 pmol of a photoreleasable small molecule and a controlled number of cells. The engineered Saccharomyces cerevisiae cells used in this study express two interacting proteins after induction with galactose whose interaction results in cell death in the presence of 5-fluoroorotic acid (inducible reverse two-hybrid assay). Disruption of the interaction by a small molecule allows growth, and the small molecule can be introduced into the system hours before induction of the toxic interaction. We demonstrate that the interaction between the activin receptor R1 and the immunophilin protein FKBP12 can be disrupted by the small molecule FK506 at nanomolar concentrations in nanodroplets. This system should provide a general method for selecting cell-permeable ligands that can be used to study the relevance of protein-protein interactions in living cells or organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.